Skip to the main content

Collegium antropologicum, Vol. 32 No. 2, 2008.

Short communication, Note

Effect of Erythropoietin in a Patient with Severe Congestive Heart Failure – A Case Report

Tea Carić
Ozren Đerek
Drago Carić

Full text: english pdf 52 Kb

page 641-643

downloads: 488

cite

Abstract

Erythropoietin (EPO), traditionally known as a hematopoietic hormone, has recently been shown to have effects beyond
hematopoiesis such as prevention of neuronal and cardiac apoptosis secondary to ischemia and induction of neoangiogenesis4,5,12,13.
Patients with congestive heart failure (CHF) suffer considerable morbidity and mortality despite advances
in therapy. Anemia, CHF, and chronic kidney insuficiency often coexist and interact to cause or worsen each other
in the so-called cardio-renal anemia syndrome3. Treatment with EPO has shown promise in such patients. The paper reviews
a case of a successful recovery of cardiac function in a patient with a severe CHF during the treatment with EPO.

Keywords

cardio-renal anemia; heart failure; erythropoietin; apoptosis

Hrčak ID:

27191

URI

https://hrcak.srce.hr/27191

Publication date:

7.7.2008.

Visits: 968 *